Interferon levels in Down's syndrome
Boyer, J.M.; Fontes, A.K.
Journal of the American Osteopathic Association 75(4): 437-441
1975
ISSN/ISBN: 0098-6151 PMID: 129490 Document Number: 92516
Document emailed within 1 workday
Related Documents
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407Grunfeld, C.; Kotler, D.P.; Shigenaga, J.K.; Doerrler, W.; Tierney, A.; Wang, J.; Pierson, R.N.; Feingold, K.R. 1991: Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome American Journal of Medicine 90(2): 154-162
Acaba, L.; Mangual, A.; Vélez García, E. 2000: Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin e levels Boletin de la Asociacion Medica de Puerto Rico 92(4-8): 59-62
Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Quartuccio, L.; Mavragani, C.P.; Nezos, A.; Gandolfo, S.; Tzioufas, A.G.; De Vita, S. 2017: Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome Clinical and Experimental Rheumatology 35(4): 719-720
Bocci, V.; Carraro, F.; Naldini, A.; Borrelli, E.; Biagi, G.; Gotti, G.; Giomarelli, P.P. 1990: Interferon levels in human pulmonary tumors are lower than plasma levels Journal of Biological Regulators and Homeostatic Agents 4(4): 153-156
Bielec, D.; Patorska-Mach, E.; Semczuk, G.; Toruń, E. 1997: Plasma levels of interferon gamma and interleukin 10 in patients with lymphonodular toxoplasmosis Przeglad Epidemiologiczny 51(1-2): 21-24
Balashov, A.M.; Surkina, I.D.; Gotovtseva, E.P.; Petrichenko, O.B.; Panchenko, L.F. 1990: Blood levels of opioid peptides and alpha interferon under the action of dipyridamole Biulleten' Eksperimental'noi Biologii i Meditsiny 109(5): 462-464
Busse, E.; Rose, H.; Helmholz, M.; Kaiser, E.; Reissbeck, K.H. 1981: Changes in interferon and thymus factor levels as well as in lymphocyte populations in patients with mammary carcinoma Zentralblatt für Gynakologie 103(12): 694-702
Brockmeyer, N.H.; Mertins, L.; Spatz, D.; Tillmann, I.; Goos, M. 1992: Endogenous interferon plasma levels and antipyrine pharmacokinetics in patients with viral infections International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 530-533
Daito, K.; Suou, T.; Kawasaki, H. 1994: Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon Research Communications in Chemical Pathology and Pharmacology 83(3): 303-316
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Baum, M.; Müller-Steinhardt, M.; Liesen, H.; Kirchner, H. 1997: Moderate and exhaustive endurance exercise influences the interferon-gamma levels in whole-blood culture supernatants European Journal of Applied Physiology and Occupational Physiology 76(2): 165-169
Crowe, D.O.; Reiners, J.J.; Nerland, D.E.; Sonnenfeld, G. 1986: Kinetics of depression and recovery of murine hepatic cytochrome P-450 levels after treatment with the interferon inducer polyriboinosinic-polyribocytidylic acid Journal of the National Cancer Institute 76(5): 879-883
Maszkiewicz, W. 1983: Serum immunoglobulin levels in newborn infants with the intrauterine dystrophy syndrome. II. Immunoglobulin levels in relation to the degree of maturity Pediatria Polska 58(3): 237-242
Notsuka, T.; Furusawa, M.; Tomoda, H.; Seo, Y.; Kurashige, S.; Kameda, K.; Sonoda, T. 1986: Intraperitoneal administration of beta-interferon in gastric cancer patients with peritoneal recurrence (ascites and serum IFN levels and its antitumor effect) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3538-3540
Robak, E.; Sysa-Jedrzejewska, A.; Dziankowska, B.; Torzecka, D.; Chojnowski, K.; Robak, T. 1998: Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity Archivum Immunologiae et Therapiae Experimentalis 46(6): 375-380
Zielinski, R.M.; Lawrence, W.D. 1990: Interferon-alpha for the hypereosinophilic syndrome Annals of Internal Medicine 113(9): 716-718
Jenab, S.; Quinones-Jenab, V. 2002: The effects of interleukin-6, leukemia inhibitory factor and interferon-gamma on STAT DNA binding and c-fos mRNA levels in cortical astrocytes and C6 glioma cells Neuro Endocrinology Letters 23(4): 325-328
Bélec, L.; Meillet, D.; Grésenguet, G.; Gherardi, R.K. 1995: Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 8(2): 212-214